Endometriosis Classification Systems: An International Survey to Map Current Knowledge and Uptake.

ENZIAN Endometriosis classification endometriosis fertility index infertility reporting revised American Society for Reproductive Medicine staging survey

Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
06 2022
Historique:
received: 24 01 2022
accepted: 25 01 2022
pubmed: 6 3 2022
medline: 15 6 2022
entrez: 5 3 2022
Statut: ppublish

Résumé

In the field of endometriosis, several classification, staging and reporting systems have been developed, but do clinicians routinely use these classification systems, which system do they use and what are the clinicians' motivations? A cross-sectional study was performed to gather data on the current use of endometriosis classification systems, problems encountered and interest in a new simple surgical descriptive system for endometriosis. Of particular focus were three systems most commonly used: the Revised American Society for Reproductive Medicine (rASRM) classification, the Endometriosis Fertility Index (EFI), and the ENZIAN classification. Data were analysed by SPSS. A survey was designed using the online SurveyMonkey tool consisting of 11 questions concerning three domains-participants background, existing classification systems and intentions with regards to a new classification system for endometriosis. Replies were collected between 15 May and 1 July 2020. na TABULATION, INTEGRATION AND RESULTS: The final dataset included the replies of 1178 clinicians, including surgeons, gynecologists, reproductive endocrinologists, fertility specialists and sonographers, all managing women with endometriosis in their clinical practice. Overall, 75.5% of the professionals indicate that they currently use a classification system for endometriosis. The rASRM classification system was the best known and used system, the EFI system and ENZIAN system were known by a majority of the professionals but used by only a minority. The lack of clinical relevance was most often selected as a problem with using any system. The findings of the survey suggest that clinicians worldwide are open to using a new classification system for endometriosis that can achieve standardized reporting, and is clinically relevant and simple. The findings therefore support future initiatives for the development of a new descriptive system for endometriosis and provide information on user expectations and conditions for universal uptake of such a system. Even with a high uptake of the existing endometriosis classification systems (rASRM, ENZIAN and EFI), most clinicians managing endometriosis would like a new simple surgical descriptive system for endometriosis.

Identifiants

pubmed: 35246388
pii: S1553-4650(22)00043-7
doi: 10.1016/j.jmig.2022.01.014
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

716-725.e1

Subventions

Organisme : Medical Research Council
ID : G0802808
Pays : United Kingdom

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Krina T Zondervan (KT)

Nuffield Department of Women's & Reproductive Health (Zondervan), University of Oxford, Oxford Endometriosis CaRe Centre, Oxford, Oxfordshire, UK; Wellcome Centre for Human Genetics (Zondervan), University of Oxford, Oxford, Oxfordshire, UK.

Stacey Missmer (S)

Department of Obstetrics, Gynecology and Reproductive Biology (Missmer), Michigan State University College of Human Medicine, East Lansing, MI, USA; Department of Epidemiology (Missmer), Harvard University T H Chan School of Public Health, Boston, MA, USA; World Endometriosis Research Foundation (Missmer), WERF, London, UK.

Mauricio S Abrao (MS)

Disciplina de Ginecologia, Departamento de Obstetricia e Ginecologia, Faculdade de Medicina FMUSP (Abrao), Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Gynecologic Division, BP-A Beneficencia Portuguesa de Sao Paulo (Missmer), Sao Paulo, SP, Brazil.

Jon I Einarsson (JI)

Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology (Einarsson), Brigham and Women's Hospital, Boston, MA, USA.

Andrew W Horne (AW)

University of Edinburgh, MRC Centre for Reproductive Health (Horne), QMRI, Edinburgh, UK.

Neil P Johnson (NP)

Robinson Research Institute (Johnson), University of Adelaide, Adelaide, SA, Australia.

Ted T M Lee (TTM)

Department of Obstetrics, Gynecology and Reproductive Sciences (Lee), Magee Womens Hospital of UPMC, Pittsburgh, PA, USA.

John Petrozza (J)

Department of Obstetrics and Gynecology, Massachusetts General Hospital Fertility Center (Petrozza), Boston, MA, USA.

Carla Tomassetti (C)

University Hospitals Leuven, Dept. Obstetrics and Gynaecology (Tomassetti), Leuven University Fertility Center, Belgium; KU Leuven, Faculty of Medicine, Dept. Development and Regeneration (Tomassetti), LEERM (Lab of Endometrium, Endometriosis and Reproductive Medicine), Belgium.

Nathalie Vermeulen (N)

ESHRE (Vermeulen), Central Office, Strombeek-Bever, Belgium.

Grigoris Grimbizis (G)

1st Dept Obstet Gynecol, Medical School (Grimbizis), Aristotle University of Thessaloniki, Thessaloniki, Greece.

Rudy Leon De Wilde (RL)

Carl von Ossietzky Universitat Oldenburg (De Wilde), University Hospital for Gynecology, Oldenburg, Germany. Electronic address: rudy-leon.dewilde@pius-hospital.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH